Jayasuriya Anula - Insider Non-Derivative Transactions at Lineage Cell Therapeutics, Inc. (LCTX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Dec 29, 2023, Jayasuriya Anula's relationship to Lineage Cell Therapeutics, Inc. (LCTX) is Director, and currently has 10,000 shares of Common Shares, no par value.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LCTX insiders.
Data Source: SEC.
Jayasuriya Anula - Insider Non-Derivative Transactions at LCTX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Dec 30, 2023 | P -- (Common Shares, no par value) | 10000 | 1.09 | 10000 |